What Is Tesamorelin? A Clear Look at the GHRH Analog Research Peptide

Tesamorelin is one of the GHRH research peptides researchers ask about most, and it is often confused with the others in that family. Here is a clear look at what it is and where it fits.

What tesamorelin is

Tesamorelin is a synthetic analog of growth hormone releasing hormone, or GHRH. According to PubMed, it was developed as a stabilized growth hormone releasing factor analog, engineered to be more stable and better tolerated than the natural hormone (Wang & Tomlinson, 2009, DOI). So it is a modified, sturdier version of the GHRH molecule.

Why the stability matters in research

The native GHRH hormone breaks down quickly. Tesamorelin was built to hold up longer, which is the property the published research centers on. That added stability is the defining trait of the compound and the reason it appears across so much growth hormone literature as an investigational GHRH analog.

How it differs from sermorelin

Tesamorelin and sermorelin both act on the GHRH receptor pathway, so they target the same route. The difference is structural. Sermorelin is the minimal active fragment of GHRH, while tesamorelin is a stabilized analog. For the full side by side, see our tesamorelin vs sermorelin comparison.

Sourcing tesamorelin

With any in-demand compound, documentation is what protects you. Look for a per batch Certificate of Analysis you can see before you buy, HPLC purity on the specific lot, mass spectrometry confirmation, and a lot number tied to your vial.

Peptide Hackers carries tesamorelin, along with the tesamorelin and ipamorelin blend, with that documentation on every batch. For researchers in the Los Angeles and Orange County areas, you can order online and pick up the same day in person, with shipping available if you prefer delivery. The full catalog is at peptidehackers.com.

All products are for laboratory research only. Not for human or veterinary use.